Patents by Inventor Andrea T. Todd

Andrea T. Todd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340514
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: January 31, 2023
    Publication date: October 26, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Patent number: 11597941
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that positively regulates alkaloid biosynthesis, such as nicotine biosynthesis. In particular, the present disclosure provides methods for the inhibition of Nicotiana benthamiana auxin response factor 1 (NbTF1) to reduce alkaloid biosynthesis in plants.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: March 7, 2023
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Publication number: 20230048978
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: May 5, 2022
    Publication date: February 16, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Publication number: 20210207158
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: February 26, 2021
    Publication date: July 8, 2021
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Patent number: 10968459
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that positively negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis. In particular, the present disclosure provides methods for the inhibition of Nicotiana benthamiana auxin response factor 1 (NbTF1) to reduce alkaloid biosynthesis in plants.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: April 6, 2021
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 10941410
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: March 9, 2021
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 10669552
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis. In particular, the present disclosure provides methods for overexpressing NbTF7 to decrease nicotine biosynthesis in plants.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: June 2, 2020
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 10337020
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: July 2, 2019
    Assignee: 22nd Century Limited LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Publication number: 20190017062
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 17, 2019
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Publication number: 20180355365
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: June 1, 2018
    Publication date: December 13, 2018
    Applicant: 22nd CENTURY LIMITED, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Publication number: 20180355364
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: May 21, 2018
    Publication date: December 13, 2018
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Publication number: 20180327766
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: July 20, 2018
    Publication date: November 15, 2018
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Patent number: 10100323
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: October 16, 2018
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 10030249
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: July 24, 2018
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 9988640
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: June 5, 2018
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 9976153
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis. In particular, the present disclosure provides methods for the inhibition of Nicotiana benthamiana auxin response factor (NbTF7) to increase alkaloid biosynthesis in plants.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: May 22, 2018
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 9879272
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: January 30, 2018
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Publication number: 20170321223
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: July 24, 2017
    Publication date: November 9, 2017
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Patent number: 9752156
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: August 30, 2015
    Date of Patent: September 5, 2017
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Patent number: 9732350
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: August 15, 2017
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd